Organon & Co | OGN - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Celltrion KRW 10.5B 4.1B 2025-12
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 9.63B 1.09B 2026-03
Gilead Sciences USD 2.08B 1.56B 2025-12
Glaxosmithkline GBP 2.46B 569M 2025-09
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Medical Developments International AUD -149K 466K 2025-06
Merck USD 3.42B 3.32B 2025-12
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Novartis USD 5.17B 637M 2025-09
Organigram Holdings CAD -41.72M 25.52M 2025-09
Organon & Co USD -148M 391M 2025-12
Pharma Mar EUR 1.6M 38.6M 2026-03
Qiagen NV USD 109.17M 25.56M 2025-12
Sartorius EUR 157.8M 76.1M 2026-03
Tilray USD -39.96M 39.19M 2025-09
Zealand Pharma A/S -406.5M 39.77M 2025-12